Safety and efficacy of vemurafenib in end stage renal failure

BACKGROUND: Serine-threonine inhibitors, such as vemurafenib, are being used increasingly in cancer treatment, and the toxicity and therapeutic benefit need to be balanced carefully both before and during treatment. CASE PRESENTATION: A patient with metastatic melanoma and end stage renal failure wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Iddawela, Mahesh, Crook, Sarah, George, Leah, Lakkaraju, Amit, Nanayakkara, Nihal, Hunt, Roland, Adam, William R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029063/
https://www.ncbi.nlm.nih.gov/pubmed/24314265
http://dx.doi.org/10.1186/1471-2407-13-581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029063/
https://www.ncbi.nlm.nih.gov/pubmed/24314265
http://dx.doi.org/10.1186/1471-2407-13-581

Ejemplares similares